Vistagen Therapeutics, Inc. · NASDAQ:VTGN

Great Point Partners LLC reported a 6.28% stake in Vistagen Therapeutics, Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Great Point Partners LLC reported a 6.28% stake in Vistagen Therapeutics, Inc., 2,055,834 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
6.28%
Shares
2,055,834
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Great Point Partners, LLC6.28%2,055,834
Dr. Jeffrey R. Jay, M.D.6.28%2,055,834
Ms. Lillian Nordahl6.28%2,055,834

Source

View original at SEC

Related